Our Pipeline

We are at the forefront of innovation and a recognized leader in the field of spheroid technology. Our proprietary platform technology harnesses the remarkable power of a patient's own cells to create a groundbreaking autologous therapy designed to combat specific diseases. Spheroids, the cornerstone of our approach, represent exceptional "mini tissues" that undergo a remarkable transformation, self-assembling from a 2D monolayer into 3D spheres.

What sets our spheroids apart is their innate programming to regenerate target tissues, making them a revolutionary force in biotechnology. This is just one element of our exciting pipeline of advancements in the field.